NCT05054868View on ClinicalTrials.gov

Ketorolac vs Oxycodone for Great Toe Arthrodesis

PHASE1UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 14, 2020

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Arthrodesis
Interventions
DRUG

Oxycodone

Subjects randomized to the control group will receive oxycodone for postop pain management (standard of care).

DRUG

Ketorolac

Subjects randomized to the treatment group will receive oxycodone and ketorolac for postop pain management.

Trial Locations (1)

21218

RECRUITING

Amy Loveland, Baltimore

Sponsors
All Listed Sponsors
lead

Medstar Health Research Institute

OTHER

NCT05054868 - Ketorolac vs Oxycodone for Great Toe Arthrodesis | Biotech Hunter | Biotech Hunter